Literature DB >> 16672757

Surgical insights into Parkinson's disease.

Erlick A C Pereira1, Tipu Z Aziz.   

Abstract

Surgery for Parkinson's disease was popularized in the mid-twentieth century before the advent of effective medical therapies. Early lesioning treatments contributed to our understanding of the functional anatomy of Parkinson's disease. Observations of the limitations and long-term complications of established pharmacological therapies for Parkinson's disease, together with major contributions from animal research to elucidate the roles of the basal ganglia in movement disorders, inspired a recent renaissance in neurosurgical interventions for Parkinson's disease including deep brain stimulation; this continues to yield much neurophysiological information. The development of potentially restorative treatment modalities, such as gene therapy, neural transplantation and nanotechnology, hold much promise for surgery, both therapeutically and in revealing further insights into Parkinson's disease pathophysiology.

Entities:  

Mesh:

Year:  2006        PMID: 16672757      PMCID: PMC1457758          DOI: 10.1177/014107680609900515

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  57 in total

1.  [Indications and localization of stereotactic brain operations].

Authors:  R HASSLER; T RIECHERT
Journal:  Nervenarzt       Date:  1954-11-20       Impact factor: 1.214

2.  Ligation of the anterior choroidal artery for involuntary movements; parkinsonism.

Authors:  I S COOPER
Journal:  Psychiatr Q       Date:  1953-04

3.  The impact of deep brain stimulation on executive function in Parkinson's disease.

Authors:  M Jahanshahi; C M Ardouin; R G Brown; J C Rothwell; J Obeso; A Albanese; M C Rodriguez-Oroz; E Moro; A L Benabid; P Pollak; P Limousin-Dowsey
Journal:  Brain       Date:  2000-06       Impact factor: 13.501

Review 4.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

5.  Surgical treatment, past and present, in Parkinson's disease.

Authors:  L Laitinen
Journal:  Acta Neurol Scand Suppl       Date:  1972

6.  Dyskinesias following neural transplantation in Parkinson's disease.

Authors:  Peter Hagell; Paola Piccini; Anders Björklund; Patrik Brundin; Stig Rehncrona; Håkan Widner; Lesley Crabb; Nicola Pavese; Wolfgang H Oertel; Niall Quinn; David J Brooks; Olle Lindvall
Journal:  Nat Neurosci       Date:  2002-07       Impact factor: 24.884

7.  Pedunculopontine nucleus stimulation improves akinesia in a Parkinsonian monkey.

Authors:  Ned Jenkinson; Dipankar Nandi; R Chris Miall; John F Stein; Tipu Z Aziz
Journal:  Neuroreport       Date:  2004-12-03       Impact factor: 1.837

8.  Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation.

Authors:  R Hilker; A T Portman; J Voges; M J Staal; L Burghaus; T van Laar; A Koulousakis; R P Maguire; J Pruim; B M de Jong; K Herholz; V Sturm; W-D Heiss; K L Leenders
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

Review 9.  Recent failures of new potential symptomatic treatments for Parkinson's disease: causes and solutions.

Authors:  Gurutz Linazasoro
Journal:  Mov Disord       Date:  2004-07       Impact factor: 10.338

10.  Observations on the Physiology and Pathology of Hemi-Chorea.

Authors:  J Hughlings-Jackson
Journal:  Edinb Med J       Date:  1868-10
View more
  6 in total

Review 1.  Role of radiology in central nervous system stimulation.

Authors:  D P Minks; E A C Pereira; V E L Young; K M Hogarth; G Quaghebeur
Journal:  Br J Radiol       Date:  2015-02-25       Impact factor: 3.039

Review 2.  Pedunculopontine stimulation from primate to patient.

Authors:  Erlick A C Pereira; Dipankar Nandi; Ned Jenkinson; John F Stein; Alexander L Green; Tipu Z Aziz
Journal:  J Neural Transm (Vienna)       Date:  2011-03-30       Impact factor: 3.575

Review 3.  Neuropathic pain and deep brain stimulation.

Authors:  Erlick A C Pereira; Tipu Z Aziz
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 4.  RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis.

Authors:  Sabrina M Heman-Ackah; Martina Hallegger; Mahendra S Rao; Matthew J A Wood
Journal:  Front Mol Neurosci       Date:  2013-11-20       Impact factor: 5.639

5.  Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson's disease.

Authors:  Jia-Nan Yan; Hai-Ying Zhang; Jun-Rui Li; Ying Chen; Yong-Cheng Jiang; Jia-Bing Shen; Kai-Fu Ke; Xiao-Su Gu
Journal:  Neural Regen Res       Date:  2022-06       Impact factor: 5.135

Review 6.  Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities.

Authors:  Antonio J Salgado; Joao C Sousa; Bruno M Costa; Ana O Pires; António Mateus-Pinheiro; F G Teixeira; Luisa Pinto; Nuno Sousa
Journal:  Front Cell Neurosci       Date:  2015-07-13       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.